0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-02-14 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14662085 2023-02-14 2024-02-29 14662085 2024-02-29 14662085 2023-02-13 14662085 bus:Director1 2023-02-14 2024-02-29 14662085 core:WithinOneYear 2024-02-29 14662085 core:UKTax 2023-02-14 2024-02-29 14662085 core:ShareCapital 2024-02-29 14662085 bus:SmallEntities 2023-02-14 2024-02-29 14662085 bus:AuditExemptWithAccountantsReport 2023-02-14 2024-02-29 14662085 bus:SmallCompaniesRegimeForAccounts 2023-02-14 2024-02-29 14662085 bus:PrivateLimitedCompanyLtd 2023-02-14 2024-02-29 14662085 bus:FullAccounts 2023-02-14 2024-02-29
COMPANY REGISTRATION NUMBER: 14662085
SM SKIN LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
29 February 2024
SM SKIN LTD
FINANCIAL STATEMENTS
PERIOD FROM 14 FEBRUARY 2023 TO 29 FEBRUARY 2024
CONTENTS
PAGE
Statement of financial position
1
Notes to the financial statements
3
SM SKIN LTD
STATEMENT OF FINANCIAL POSITION
29 February 2024
29 Feb 24
Note
£
CURRENT ASSETS
Debtors
4
4,108
Cash at bank and in hand
30
--------
4,138
CREDITORS: amounts falling due within one year
5
4,137
--------
NET CURRENT ASSETS
1
-----
TOTAL ASSETS LESS CURRENT LIABILITIES
1
-----
NET ASSETS
1
-----
SM SKIN LTD
STATEMENT OF FINANCIAL POSITION (continued)
29 February 2024
29 Feb 24
Note
£
CAPITAL AND RESERVES
Called up share capital
1
-----
SHAREHOLDERS FUNDS
1
-----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 4 November 2024 , and are signed on behalf of the board by:
L Sylvester
Director
Company registration number: 14662085
SM SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS
PERIOD FROM 14 FEBRUARY 2023 TO 29 FEBRUARY 2024
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Onega House, 112 Main Road, Sidcup, DA14 6NE, United Kingdom.
2. ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
3. TAX ON PROFIT
Major components of tax expense
Period from
14 Feb 23 to
29 Feb 24
£
Current tax:
UK current tax expense
2,697
--------
Tax on profit
2,697
--------
4. DEBTORS
29 Feb 24
£
Other debtors
4,108
--------
5. CREDITORS: amounts falling due within one year
29 Feb 24
£
Corporation tax
2,697
Other creditors
1,440
--------
4,137
--------
6. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES
At 29th February 2024 the director owed SM Skin Ltd £XXX. There are no terms attached to the loan provided to the director and it has been provided by the company interest free.